Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

[Relationship between pregnancy factors and low birth weight infants, miscarriages, and stillbirths: A follow-up survey on birth conditions of pregnant women who received the maternal and child health handbook from public health nurses and midwives].

Naito M, Tsushima M, Hayata M, Senjyu R, Ueda S, Mizushima H, Tahara Y, Urabe F, Mori M, Ishitake T.

Nihon Koshu Eisei Zasshi. 2019;66(8):397-406. doi: 10.11236/jph.66.8_397. Japanese.

2.

The use of green fluorescent protein-tagged virus-like particles as a tracer in the early phase of chikungunya infection.

Tumkosit U, Maeda Y, Kishishita N, Siripanyaphinyo U, Omori H, Chetanachan P, Sittisaman P, Jityam C, Priengprom T, Mizushima H, Wongjaroen P, Mekada E, Tatsumi M, Takeda N, Tanaka A.

Virus Res. 2019 Oct 15;272:197732. doi: 10.1016/j.virusres.2019.197732. Epub 2019 Aug 21.

PMID:
31445103
3.

The Survey for Determining Knowledge-Related Problems in the Dissemination of ICD-11.

Nishio A, Kimura E, Seto R, Sato Y, Mizushima H.

Stud Health Technol Inform. 2019 Aug 21;264:1865-1866. doi: 10.3233/SHTI190687.

PMID:
31438382
4.

The dynamics of norovirus genotypes and genetic analysis of a novel recombinant GII.P12-GII.3 among infants and children in Bangkok, Thailand between 2014 and 2016.

Boonchan M, Guntapong R, Sripirom N, Ruchusatsawat K, Singchai P, Rungnobhakhun P, Tacharoenmuang R, Mizushima H, Tatsumi M, Takeda N, Sangkitporn S, Mekmullica J, Motomura K.

Infect Genet Evol. 2018 Jun;60:133-139. doi: 10.1016/j.meegid.2018.02.028. Epub 2018 Feb 20.

PMID:
29471118
5.

Establishment of New National Rare Disease (Nambyo) Registry and Registry Guidelines in Japan.

Mizushima H, Tanabe M, Sugamori Y, Sato Y, Ogata H.

Stud Health Technol Inform. 2017;245:536-538.

PMID:
29295152
6.

Efficacy of the combined use of a mild foaming cleanser and moisturizer for the care of infant skin.

Okamoto N, Umehara K, Sonoda J, Hotta M, Mizushima H, Takagi Y, Matsuo K, Baba N.

Clin Cosmet Investig Dermatol. 2017 Oct 3;10:393-401. doi: 10.2147/CCID.S140716. eCollection 2017.

7.

Effect of physisorption of inert organic molecules on Au(111) surface electronic states.

Mizushima H, Koike H, Kuroda K, Ishida Y, Nakayama M, Mase K, Kondo T, Shin S, Kanai K.

Phys Chem Chem Phys. 2017 Jul 19;19(28):18646-18651. doi: 10.1039/c7cp04232a.

PMID:
28692082
8.

ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis.

Iwamoto R, Mine N, Mizushima H, Mekada E.

J Cell Sci. 2017 Apr 1;130(7):1321-1332. doi: 10.1242/jcs.196618. Epub 2017 Feb 23.

9.

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study.

Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, Nam SO, Fukagawa S, Katsuta T, Maehara M, Kondo H, Miyahara D, Shirota K, Yoshizato T, Kuroki M, Nishikawa H, Saku K, Tsuboi Y, Ishitsuka K, Takamatsu Y, Tamura K, Matsunaga A, Hachisuga T, Nishino S, Odawara T, Maeda K, Manabe S, Ishikawa T, Okuno Y, Ohishi M, Hikita T, Mizushima H, Iwamoto R, Mekada E.

BMC Cancer. 2017 Jan 31;17(1):89. doi: 10.1186/s12885-017-3071-5.

10.

National Registry of Designated Intractable Diseases in Japan: Present Status and Future Prospects.

Kanatani Y, Tomita N, Sato Y, Eto A, Omoe H, Mizushima H.

Neurol Med Chir (Tokyo). 2017 Jan 15;57(1):1-7. doi: 10.2176/nmc.st.2016-0135. Epub 2016 Sep 21.

11.

Neurological Deficits before and after Surgical Resection of Schwannomas in the Upper Extremities.

Mizushima H.

J Reconstr Microsurg. 2016 Jun;32(5):371-7. doi: 10.1055/s-0036-1571798. Epub 2016 Feb 12.

PMID:
26872028
12.

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.

Masuda T, Ishikawa T, Mogushi K, Okazaki S, Ishiguro M, Iida S, Mizushima H, Tanaka H, Uetake H, Sugihara K.

Int J Oncol. 2016 Mar;48(3):975-82. doi: 10.3892/ijo.2016.3329. Epub 2016 Jan 11.

13.

Prediction of prognosis of ALS: Importance of active denervation findings of the cervical-upper limb area and trunk area.

Sato Y, Nakatani E, Watanabe Y, Fukushima M, Nakashima K, Kannagi M, Kanatani Y, Mizushima H.

Intractable Rare Dis Res. 2015 Nov;4(4):181-9. doi: 10.5582/irdr.2015.01043.

14.

Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.

Takahashi H, Ishikawa T, Ishiguro M, Okazaki S, Mogushi K, Kobayashi H, Iida S, Mizushima H, Tanaka H, Uetake H, Sugihara K.

BMC Cancer. 2015 Oct 24;15:794. doi: 10.1186/s12885-015-1783-y.

15.

Sialylation potentials of the silkworm, Bombyx mori; B. mori possesses an active α2,6-sialyltransferase.

Kajiura H, Hamaguchi Y, Mizushima H, Misaki R, Fujiyama K.

Glycobiology. 2015 Dec;25(12):1441-53. doi: 10.1093/glycob/cwv060. Epub 2015 Aug 24.

PMID:
26306633
16.

Structural basis for the Ca(2+)-enhanced thermostability and activity of PET-degrading cutinase-like enzyme from Saccharomonospora viridis AHK190.

Miyakawa T, Mizushima H, Ohtsuka J, Oda M, Kawai F, Tanokura M.

Appl Microbiol Biotechnol. 2015 May;99(10):4297-307. doi: 10.1007/s00253-014-6272-8. Epub 2014 Dec 11.

PMID:
25492421
17.

Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGF.

Suzuki K, Mizushima H, Abe H, Iwamoto R, Nakamura H, Mekada E.

J Biochem. 2015 May;157(5):331-43. doi: 10.1093/jb/mvu079. Epub 2014 Nov 27.

PMID:
25432160
18.

PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.

Eslami A, Miyaguchi K, Mogushi K, Watanabe H, Okada N, Shibuya H, Mizushima H, Miura M, Tanaka H.

Br J Cancer. 2015 Jan 20;112(2):338-44. doi: 10.1038/bjc.2014.590. Epub 2014 Nov 25.

19.

A novel Ca²⁺-activated, thermostabilized polyesterase capable of hydrolyzing polyethylene terephthalate from Saccharomonospora viridis AHK190.

Kawai F, Oda M, Tamashiro T, Waku T, Tanaka N, Yamamoto M, Mizushima H, Miyakawa T, Tanokura M.

Appl Microbiol Biotechnol. 2014 Dec;98(24):10053-64. doi: 10.1007/s00253-014-5860-y. Epub 2014 Jun 15.

PMID:
24929560
20.

[Patient database and orphan drug development].

Mizushima H, Tanabe M, Kanatani Y.

Yakugaku Zasshi. 2014;134(5):599-605. Review. Japanese.

21.

Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.

Obulhasim G, Yasen M, Kajino K, Mogushi K, Tanaka S, Mizushima H, Tanaka H, Arii S, Hino O.

Hepatol Int. 2013 Mar;7(1):215-25. doi: 10.1007/s12072-012-9357-4. Epub 2012 Mar 13.

PMID:
26201636
22.

Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.

Yokota S, Hikasa Y, Mizushima H.

Pharmacology. 2013;91(3-4):135-44. doi: 10.1159/000346269. Epub 2013 Jan 25.

PMID:
23364471
23.

Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling.

Katayama Y, Maeda M, Miyaguchi K, Nemoto S, Yasen M, Tanaka S, Mizushima H, Fukuoka Y, Arii S, Tanaka H.

Oncol Lett. 2012 Oct;4(4):817-823. Epub 2012 Jul 18.

24.

Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis.

Kikuchi A, Ishikawa T, Mogushi K, Ishiguro M, Iida S, Mizushima H, Uetake H, Tanaka H, Sugihara K.

Int J Cancer. 2013 May 15;132(10):2295-302. doi: 10.1002/ijc.27911. Epub 2012 Nov 5.

25.

Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.

Mayinuer A, Yasen M, Mogushi K, Obulhasim G, Xieraili M, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Ann Surg Oncol. 2013 Jan;20(1):305-17. doi: 10.1245/s10434-012-2395-2. Epub 2012 Oct 13.

26.

Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Xieraili M, Yasen M, Mogushi K, Obulhasim G, Mayinuer A, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Cancer Sci. 2012 Aug;103(8):1493-501. doi: 10.1111/j.1349-7006.2012.02315.x. Epub 2012 May 25.

27.

Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile.

Khamas A, Ishikawa T, Shimokawa K, Mogushi K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H, Sugihara K.

Cancer Genomics Proteomics. 2012 Mar-Apr;9(2):67-75.

PMID:
22399497
28.

Genome-wide integrative analysis revealed a correlation between lengths of copy number segments and corresponding gene expression profile.

Miyaguchi K, Fukuoka Y, Mizushima H, Yasen M, Nemoto S, Ishikawa T, Uetake H, Tanaka S, Sugihara K, Arii S, Tanaka H.

Bioinformation. 2011;7(6):280-4. Epub 2011 Nov 20.

29.

Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.

Miyaguchi K, Uzawa N, Mogushi K, Takahashi K, Michikawa C, Nakata Y, Sumino J, Okada N, Mizushima H, Fukuoka Y, Tanaka H.

Int J Oncol. 2012 Jun;40(6):1907-14. doi: 10.3892/ijo.2012.1373. Epub 2012 Feb 14.

PMID:
22344708
30.

DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.

Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, Tanaka H, Hino O, Arii S.

Int J Oncol. 2012 Mar;40(3):789-97. doi: 10.3892/ijo.2011.1282. Epub 2011 Dec 6.

PMID:
22159460
31.

[Psychoeducation and interpersonal and social rhythm therapy for bipolar disorder].

Mizushima H.

Seishin Shinkeigaku Zasshi. 2011;113(9):880-5. Review. Japanese.

PMID:
22117393
32.

HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers.

Murata T, Mizushima H, Chinen I, Moribe H, Yagi S, Hoffman RM, Kimura T, Yoshino K, Ueda Y, Enomoto T, Mekada E.

Cancer Res. 2011 Nov 1;71(21):6633-42. doi: 10.1158/0008-5472.CAN-11-0034. Epub 2011 Oct 18.

33.

Clinical significance of UNC5B expression in colorectal cancer.

Okazaki S, Ishikawa T, Iida S, Ishiguro M, Kobayashi H, Higuchi T, Enomoto M, Mogushi K, Mizushima H, Tanaka H, Uetake H, Sugihara K.

Int J Oncol. 2012 Jan;40(1):209-16. doi: 10.3892/ijo.2011.1201. Epub 2011 Sep 15.

PMID:
21922135
34.

Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis.

Muto T, Taniguchi H, Kushima R, Tsuda H, Yonemori H, Chen C, Sugihara Y, Sakamoto K, Kobori Y, Palmer H, Nakamura Y, Tomonaga T, Tanaka H, Mizushima H, Fujita S, Kondo T.

J Proteomics. 2011 May 16;74(6):858-73. doi: 10.1016/j.jprot.2011.02.030. Epub 2011 Mar 6.

PMID:
21385629
35.

Clinical significance of osteoprotegerin expression in human colorectal cancer.

Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K.

Clin Cancer Res. 2011 Apr 15;17(8):2444-50. doi: 10.1158/1078-0432.CCR-10-2884. Epub 2011 Jan 26.

36.

iCOD: an integrated clinical omics database based on the systems-pathology view of disease.

Shimokawa K, Mogushi K, Shoji S, Hiraishi A, Ido K, Mizushima H, Tanaka H.

BMC Genomics. 2010 Dec 2;11 Suppl 4:S19. doi: 10.1186/1471-2164-11-S4-S19.

37.

The INTERMED Japanese version: inter-rater reliability and internal consistency.

Kishi Y, Matsuki M, Mizushima H, Matsuki H, Ohmura Y, Horikawa N.

J Psychosom Res. 2010 Dec;69(6):583-6. doi: 10.1016/j.jpsychores.2010.02.006. Epub 2010 Mar 30.

PMID:
21109046
38.

Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.

Koshikawa N, Mizushima H, Minegishi T, Eguchi F, Yotsumoto F, Nabeshima K, Miyamoto S, Mekada E, Seiki M.

Cancer Sci. 2011 Jan;102(1):111-6. doi: 10.1111/j.1349-7006.2010.01748.x. Epub 2010 Oct 14.

39.

Up-regulation of PSF1 promotes the growth of breast cancer cells.

Nakahara I, Miyamoto M, Shibata T, Akashi-Tanaka S, Kinoshita T, Mogushi K, Oda K, Ueno M, Takakura N, Mizushima H, Tanaka H, Ohta T.

Genes Cells. 2010 Oct;15(10):1015-24. doi: 10.1111/j.1365-2443.2010.01442.x. Epub 2010 Sep 5.

40.

Methylated BNIP3 gene in colorectal cancer prognosis.

Shimizu S, Iida S, Ishiguro M, Uetake H, Ishikawa T, Takagi Y, Kobayashi H, Higuchi T, Enomoto M, Mogushi K, Mizushima H, Tanaka H, Sugihara K.

Oncol Lett. 2010 Sep;1(5):865-872. Epub 2010 Sep 1.

41.

Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

Yoshida T, Kobayashi T, Itoda M, Muto T, Miyaguchi K, Mogushi K, Shoji S, Shimokawa K, Iida S, Uetake H, Ishikawa T, Sugihara K, Mizushima H, Tanaka H.

Cancer Inform. 2010 Jul 29;9:147-61.

42.

Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.

Koshikawa N, Mizushima H, Minegishi T, Iwamoto R, Mekada E, Seiki M.

Cancer Res. 2010 Jul 15;70(14):6093-103. doi: 10.1158/0008-5472.CAN-10-0346. Epub 2010 Jun 29.

43.

MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer.

Matsuyama T, Ishikawa T, Mogushi K, Yoshida T, Iida S, Uetake H, Mizushima H, Tanaka H, Sugihara K.

Int J Cancer. 2010 Nov 15;127(10):2292-9. doi: 10.1002/ijc.25256.

44.

Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures.

Mizushima H, Wang X, Miyamoto S, Mekada E.

J Cell Sci. 2009 Dec 1;122(Pt 23):4277-86. doi: 10.1242/jcs.054551. Epub 2009 Nov 3.

45.

The phenotype and genotype experiment object model (PaGE-OM): a robust data structure for information related to DNA variation.

Brookes AJ, Lehvaslaiho H, Muilu J, Shigemoto Y, Oroguchi T, Tomiki T, Mukaiyama A, Konagaya A, Kojima T, Inoue I, Kuroda M, Mizushima H, Thorisson GA, Dash D, Rajeevan H, Darlison MW, Woon M, Fredman D, Smith AV, Senger M, Naito K, Sugawara H.

Hum Mutat. 2009 Jun;30(6):968-77. doi: 10.1002/humu.20973.

PMID:
19479963
46.

Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.

Yasen M, Mizushima H, Mogushi K, Obulhasim G, Miyaguchi K, Inoue K, Nakahara I, Ohta T, Aihara A, Tanaka S, Arii S, Tanaka H.

Cancer Sci. 2009 Mar;100(3):472-80. doi: 10.1111/j.1349-7006.2008.01068.x. Epub 2009 Jan 2.

47.

Economic advantage of pharmacogenomics - clinical trials with genetic information.

Ohashi W, Mizushima H, Tanaka H.

Stud Health Technol Inform. 2008;136:585-90.

PMID:
18487794
48.

Development of a telediagnosis endoscopy system over secure internet.

Ohashi K, Sakamoto N, Watanabe M, Mizushima H, Tanaka H.

Methods Inf Med. 2008;47(2):157-66.

PMID:
18338087
49.

Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects.

Takayanagi R, Mizushima H, Ozeki T, Yokoyama H, Iga T, Yamada Y.

Biol Pharm Bull. 2007 Jul;30(7):1297-300.

50.

Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity.

Kageyama T, Ohishi M, Miyamoto S, Mizushima H, Iwamoto R, Mekada E.

J Biochem. 2007 Jul;142(1):95-104. Epub 2007 May 24.

PMID:
17525101

Supplemental Content

Loading ...
Support Center